Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival.

Iqbal MS, Chaw C, Kovarik J, Aslam S, Jackson A, Kelly J, Dobrowsky W, Kelly C.

Int Arch Otorhinolaryngol. 2017 Apr;21(2):171-177. doi: 10.1055/s-0036-1594020. Epub 2016 Dec 19.

2.

Spindle cell carcinoma of the head and neck region: treatment and outcomes of 15 patients.

Iqbal MS, Paleri V, Brown J, Greystoke A, Dobrowsky W, Kelly C, Kovarik J.

Ecancermedicalscience. 2015 Nov 18;9:594. doi: 10.3332/ecancer.2015.594. eCollection 2015.

3.

Small cell neuroendocrine carcinoma of larynx: case series and literature review.

Iqbal MS, Paleri V, Moor J, Dobrowsky W, Kelly C, Kovarik J.

J Laryngol Otol. 2015 Sep;129(9):910-5. doi: 10.1017/S0022215115001668. Epub 2015 Jul 15. Review.

PMID:
26173932
4.

Cutaneous metastases from head and neck squamous cell carcinoma.

Poovaneswaran S, Paleri V, Charlton F, Dobrowsky W, Kelly C.

Med J Malaysia. 2012 Aug;67(4):430-2.

5.

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.

Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, Tenesa A, Spain S, Broderick P, Ooi LY, Domingo E, Smillie C, Henrion M, Frampton M, Martin L, Grimes G, Gorman M, Semple C, Ma YP, Barclay E, Prendergast J, Cazier JB, Olver B, Penegar S, Lubbe S, Chander I, Carvajal-Carmona LG, Ballereau S, Lloyd A, Vijayakrishnan J, Zgaga L, Rudan I, Theodoratou E; Colorectal Tumour Gene Identification (CORGI) Consortium, Starr JM, Deary I, Kirac I, Kovacević D, Aaltonen LA, Renkonen-Sinisalo L, Mecklin JP, Matsuda K, Nakamura Y, Okada Y, Gallinger S, Duggan DJ, Conti D, Newcomb P, Hopper J, Jenkins MA, Schumacher F, Casey G, Easton D, Shah M, Pharoah P, Lindblom A, Liu T; Swedish Low-Risk Colorectal Cancer Study Group, Smith CG, West H, Cheadle JP; COIN Collaborative Group, Midgley R, Kerr DJ, Campbell H, Tomlinson IP, Houlston RS.

Nat Genet. 2012 May 27;44(7):770-6. doi: 10.1038/ng.2293.

6.

A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer.

Rondeau V, Pignon JP, Michiels S; MACH-NC collaborative Group.

Stat Methods Med Res. 2015 Dec;24(6):711-29. doi: 10.1177/0962280211425578. Epub 2011 Oct 23.

PMID:
22025414
7.

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Adams RA, Meade AM, Seymour MT, Wilson RH, Madi A, Fisher D, Kenny SL, Kay E, Hodgkinson E, Pope M, Rogers P, Wasan H, Falk S, Gollins S, Hickish T, Bessell EM, Propper D, Kennedy MJ, Kaplan R, Maughan TS; MRC COIN Trial Investigators.

Lancet Oncol. 2011 Jul;12(7):642-53. doi: 10.1016/S1470-2045(11)70102-4. Epub 2011 Jun 5.

8.

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Maughan TS, Adams RA, Smith CG, Meade AM, Seymour MT, Wilson RH, Idziaszczyk S, Harris R, Fisher D, Kenny SL, Kay E, Mitchell JK, Madi A, Jasani B, James MD, Bridgewater J, Kennedy MJ, Claes B, Lambrechts D, Kaplan R, Cheadle JP; MRC COIN Trial Investigators.

Lancet. 2011 Jun 18;377(9783):2103-14. doi: 10.1016/S0140-6736(11)60613-2. Epub 2011 Jun 5.

9.

Priorities for the head and neck cancer patient, their companion and members of the multidisciplinary team and decision regret.

Gill SS, Frew J, Fry A, Adam J, Paleri V, Dobrowsky W, Chatterjee S, Kelly CG.

Clin Oncol (R Coll Radiol). 2011 Oct;23(8):518-24. doi: 10.1016/j.clon.2011.03.014. Epub 2011 May 6.

PMID:
21550217
10.

Impact of deprivation on short- and long-term outcomes after colorectal cancer surgery.

Bharathan B, Welfare M, Borowski DW, Mills SJ, Steen IN, Kelly SB; Northern Region Colorectal Cancer Audit Group (NORCCAG).

Br J Surg. 2011 Jun;98(6):854-65. doi: 10.1002/bjs.7427. Epub 2011 Mar 30.

PMID:
21452190
11.

Effect of the circumferential resection margin on survival following rectal cancer surgery.

Kelly SB, Mills SJ, Bradburn DM, Ratcliffe AA, Borowski DW; Northern Region Colorectal Cancer Audit Group.

Br J Surg. 2011 Apr;98(4):573-81. doi: 10.1002/bjs.7372. Epub 2011 Jan 25.

PMID:
21267989
12.

Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre.

Chatterjee S, Mott JH, Smyth G, Dickson S, Dobrowsky W, Kelly CG.

Br J Radiol. 2011 Apr;84(1000):358-66. doi: 10.1259/bjr/19586137. Epub 2010 Dec 15.

13.

Hyperfractionated or accelerated radiotherapy for head and neck cancer.

Baujat B, Bourhis J, Blanchard P, Overgaard J, Ang KK, Saunders M, Le Maître A, Bernier J, Horiot JC, Maillard E, Pajak TF, Poulsen MG, Bourredjem A, O'Sullivan B, Dobrowsky W, Andrzej H, Skladowski K, Hay JH, Pinto LH, Fu KK, Fallai C, Sylvester R, Pignon JP; MARCH Collaborative Group.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD002026. doi: 10.1002/14651858.CD002026. Review.

PMID:
21154350
14.

Volume-outcome analysis of colorectal cancer-related outcomes.

Borowski DW, Bradburn DM, Mills SJ, Bharathan B, Wilson RG, Ratcliffe AA, Kelly SB; Northern Region Colorectal Cancer Audit Group (NORCCAG).

Br J Surg. 2010 Sep;97(9):1416-30. doi: 10.1002/bjs.7111.

PMID:
20632311
15.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group.

Radiother Oncol. 2009 Jul;92(1):4-14. doi: 10.1016/j.radonc.2009.04.014. Epub 2009 May 14.

PMID:
19446902
16.

Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients.

Widder J, Kastenberger R, Fercher E, Schmid R, Langendijk JA, Dobrowsky W, Pötter R.

Radiother Oncol. 2008 Jun;87(3):367-75. doi: 10.1016/j.radonc.2008.05.001. Epub 2008 May 22.

PMID:
18501453
17.

Involvement of surgical trainees in surgery for colorectal cancer and their effect on outcome.

Borowski DW, Ratcliffe AA, Bharathan B, Gunn A, Bradburn DM, Mills SJ, Wilson RG, Kelly SB; Northern Region Colorectal Cancer Audit Group (NORCCAG).

Colorectal Dis. 2008 Oct;10(8):837-45. doi: 10.1111/j.1463-1318.2007.01465.x. Epub 2008 Mar 3.

PMID:
18318753
18.

AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cancer cervix: initial results of an IAEA multicentre randomized trial.

Dobrowsky W, Huigol NG, Jayatilake RS, Kizilbash NI, Okkan S, Kagiya TV, Tatsuzaki H.

J Cancer Res Ther. 2005 Apr-Jun;1(2):75-8.

19.

AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.

Dobrowsky W, Huigol NG, Jayatilake RS, Kizilbash NI, Okkan S, Kagiya VT, Tatsuzaki H.

Radiother Oncol. 2007 Jan;82(1):24-9. Epub 2006 Dec 11.

PMID:
17161478
20.

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maître A, Pajak TF, Poulsen MG, O'Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP; Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group.

Lancet. 2006 Sep 2;368(9538):843-54. Review.

PMID:
16950362

Supplemental Content

Loading ...
Support Center